default author photo

Joan O’Donnell

Health Protection Surveillance Centre (HPSC)

Dublin

Ireland

SCHOLARLY PAPERS

3

DOWNLOADS

336

TOTAL CITATIONS

0

Scholarly Papers (3)

1.

Age Specific Associations Between Underlying Conditions and Hospitalisation, Death and In-Hospital Death Among Confirmed COVID-19 Cases: A Multi-Country Study Based on Surveillance Data

Number of pages: 21 Posted: 31 Aug 2021
European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control, Superintendence of Public Health - Infectious Disease Prevention and Control Unit, Superintendence of Public Health, Superintendence of Public Health - Infectious Disease Prevention and Control Unit, National Institute of Public Health (Prague) - Department of Biostatistics, National Institute of Public Health (Prague) - Department of Biostatistics, National Institute of Public Health (Czech Republic) - Department of Infectious Diseases Epidemiology, National Institute of Public Health (Prague) - Department of Biostatistics, Norwegian Institute of Public Health - Division of Infection Control and Environmental Health, Norwegian Institute of Public Health - Division of Infection Control and Environmental Health, Norwegian Institute of Public HealthNorwegian Institute of Public Health - Division of Infection Control and Environmental Health, Norwegian Institute of Public Health - Division of Infection Control and Environmental Health, Health Directorate, Luxembourg, Health Directorate, Luxembourg, Health Directorate, Luxembourg, Health Protection Surveillance Centre (HPSC), Health Protection Surveillance Centre (HPSC), Health Protection Surveillance Centre (HPSC), Health Protection Surveillance Centre (HPSC), World Health Organization (WHO) - World Health Organization Regional Office for Europe, World Health Organization (WHO) - World Health Organization Regional Office for Europe and European Centre for Disease Prevention and Control
Downloads 170 (442,467)

Abstract:

Loading...

SARS-CoV-2; COVID-19; underlying health conditions; hospitalisation; death, in-hospital death

2.

Effectiveness of XBB.1.5 Vaccines against Symptomatic SARS-CoV-2 Infection in Older Adults during the JN.1 Lineage-Predominant Period, European VEBIS Primary Care Multicentre Study, 20 November 2023–1 March 2024

Number of pages: 17 Posted: 11 Jul 2024
Epiconcept - Epidemiology Department, Epiconcept, National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Carlos III Institute of Health, Health Protection Surveillance Centre (HPSC), Sorbonne University - Institut Pierre Louis d'Épidémiologie et de Santé Publique IPLESP, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, Robert Koch Institute, NIVEL (Netherlands Institute for Health Services Research), National Health Institute Doutor Ricardo Jorge (INSA) - Epidemiology Department, Semmelweis University, Public Health Agency of Sweden, Croatian Institute of Public Health, Cantacuzino National Military Medical Institute for Research and Development, Epiconcept, Consejería de Sanidad - Dirección General de Salud Pública, University College Dublin (UCD), University of Paris-Saclay - Laboratoire de Microbiologie, Universidad Pública de Navarra - IdiSNA, Navarra Institute for Health Research, Robert Koch Institute, National Institute for Public Health and the Environment (RIVM) - Centre for Infectious Disease Control, National Institute of Health Doutor Ricardo Jorge, Semmelweis University, Public Health Agency of Sweden, Croatian Institute of Public Health, National Institute for Public Health and the Environment (RIVM), National Institute of Health Doutor Ricardo Jorge, European Centre for Disease Prevention and Control, European Centre for Disease Prevention and Control and Epiconcept
Downloads 105 (664,543)

Abstract:

Loading...

COVID-19, SARS-CoV-2, Vaccine effectiveness, Primary care, Case-control study, Test-negative design, Multi-country study

3.

Protective Effect of Antiviral Treatment of Hospitalised Influenza Patients on the Risk of Death, EU 2010-2020

Number of pages: 21 Posted: 07 Feb 2022
European Centre for Disease Prevention and Control, Carlos III Institute of Health - National Center for Epidemiology, Public Health Agency of Sweden, Carlos III Institute of Health - Communicable Diseases Department, National Institute of Public Health Romania-National Centre for Communicable Diseases Surveillance and Control, Sciensano - Department of Epidemiology and Public Health, Sciensano, National Institute of Public Health (Czech Republic) - Department of Infectious Diseases Epidemiology, National Institute of Public Health (Czech Republic) - Department of Infectious Diseases Epidemiology, Public Health Agency of Sweden, National Health Institute Doutor Ricardo Jorge (INSA) - National Influenza Reference Laboratory, Medical University of Vienna - Department of Virology, Superintendence of Public Health - Infectious Disease Prevention and Control Unit, Superintendence of Public Health - Infectious Disease Prevention and Control Unit, National Institute for Public Health and the Environment (RIVM), National Institute for Public Health and the Environment (RIVM), Health Protection Surveillance Centre (HPSC), Health Protection Surveillance Centre (HPSC) and Government of the United States of America - Centers for Disease Control and Prevention (CDC)
Downloads 61 (951,658)

Abstract:

Loading...

EU, fatal outcome, influenza, hospital, antiviral treatment, risk factors